Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Petric

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Canadian Liver Journal|August 22, 2022
Stability of hepatitis B viral load during pregnancy and implications for antepartum prophylaxis: A prospective cohort studyClara Van Ommen, Arianne Albert, Melica Nourmoussavi, et al.
The Journal of Infectious Diseases|September 22, 2017
Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, CanadaDanuta M Skowronski, Catharine Chambers, Gaston De Serres, et al.
Vaccine|August 22, 2006
Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: implications for a subunit vaccineAlexander N Zakhartchouk, Chetna Sharon, Malathy Satkunarajah, et al.
Science (New York, N.Y.)|February 23, 2013
Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activityJin-Hyo Kim, Ricardo Resende, Tom Wennekes, et al.
The Journal of Infectious Diseases|March 19, 2015
Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza SeasonDanuta M Skowronski, Catharine Chambers, Suzana Sabaiduc, et al.
The Journal of Infectious Diseases|February 10, 2017
Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015Danuta M Skowronski, Catharine Chambers, Gaston De Serres, et al.
Plos One|January 30, 2014
Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease riskDanuta M Skowronski, Marie-Eve Hamelin, Gaston De Serres, et al.
The Journal of Infectious Diseases|April 12, 2012
Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variantsNaveed Z Janjua, Danuta M Skowronski, Gaston De Serres, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 28, 2012
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 seasonDanuta M Skowronski, Naveed Z Janjua, Gaston De Serres, et al.
The Journal of Infectious Diseases|January 22, 2014
Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccineDanuta M Skowronski, Naveed Z Janjua, Suzana Sabaiduc, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Canadian Liver Journal|August 22, 2022
Stability of hepatitis B viral load during pregnancy and implications for antepartum prophylaxis: A prospective cohort studyClara Van Ommen, Arianne Albert, Melica Nourmoussavi, et al.
The Journal of Infectious Diseases|September 22, 2017
Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, CanadaDanuta M Skowronski, Catharine Chambers, Gaston De Serres, et al.
Vaccine|August 22, 2006
Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: implications for a subunit vaccineAlexander N Zakhartchouk, Chetna Sharon, Malathy Satkunarajah, et al.
Science (New York, N.Y.)|February 23, 2013
Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activityJin-Hyo Kim, Ricardo Resende, Tom Wennekes, et al.
The Journal of Infectious Diseases|March 19, 2015
Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza SeasonDanuta M Skowronski, Catharine Chambers, Suzana Sabaiduc, et al.
The Journal of Infectious Diseases|February 10, 2017
Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015Danuta M Skowronski, Catharine Chambers, Gaston De Serres, et al.
Plos One|January 30, 2014
Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease riskDanuta M Skowronski, Marie-Eve Hamelin, Gaston De Serres, et al.
The Journal of Infectious Diseases|April 12, 2012
Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variantsNaveed Z Janjua, Danuta M Skowronski, Gaston De Serres, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 28, 2012
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 seasonDanuta M Skowronski, Naveed Z Janjua, Gaston De Serres, et al.
The Journal of Infectious Diseases|January 22, 2014
Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccineDanuta M Skowronski, Naveed Z Janjua, Suzana Sabaiduc, et al.
Pageof 10